[go: up one dir, main page]

Yang et al., 2023 - Google Patents

Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection

Yang et al., 2023

Document ID
15835997312523164756
Author
Yang J
Meng L
Li Y
Huang H
Publication year
Publication venue
Food & Function

External Links

Snippet

The vital role of probiotics in the food field has been widely recognized, and at the same time, probiotics are gradually exhibiting surprising effects in the field of nutraceuticals, especially in regulating gut inflammation and the nutritional environment. As a dietary …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Abbasi et al. The biological activities of postbiotics in gastrointestinal disorders
Pace et al. Probiotics in digestive diseases: focus on Lactobacillus GG.
Liu et al. Probiotics in disease prevention and treatment
JP6444358B2 (en) Pharmaceutical composition containing pediococcus and method for reducing symptoms of digestive syndrome
Verna et al. Use of probiotics in gastrointestinal disorders: what to recommend?
JP6130379B2 (en) Composition comprising N-acetylcysteine and / or microencapsulated gastroprotective lysozyme in combination with probiotic bacteria capable of repairing the gastric barrier effect lost during gastric acidity drug treatment
Bengmark Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics
Pham et al. Probiotics: sorting the evidence from the myths
Hajela et al. Gut microbiome, gut function, and probiotics: Implications for health
US20200121740A1 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
BRPI0616960A2 (en) Use of lactobacillus for the treatment of viral infections
CA2748200A1 (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
Yang et al. Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection
Orlando et al. RETRACTED ARTICLE: Intestinal Microbiota, Probiotics and Human Gastrointestinal Cancers
Xu et al. Effective regulation of gut microbiota with probiotics and prebiotics may prevent or alleviate COVID-19 through the gut-lung axis
Kahouli et al. Identification of lactobacillus fermentum strains with potential against colorectal cancer by characterizing short chain fatty acids production, anti-proliferative activity and survival in an intestinal fluid: In vitro analysis
Lou et al. Postbiotics as potential new therapeutic agents for sepsis
Vitetta et al. Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods
Prakash et al. Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Wasilewska et al. Effectiveness and safety of probiotic preparations in clinical treatment of inflammatory bowel disease.
AU2016203744A1 (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
Stevenson et al. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome
Ashraf et al. Probiotics: mechanism of action, health benefits and their application in food industries
Gionchetti et al. Probiotics, prebiotics, and antibiotics in IBD
Evangelia et al. Gut Microbiome and Gastrointestinal Disorders